Zhejiang Huangma Technology (603181.SH) plans to launch an employee stock ownership plan in 2026.
Real Madrid Technology (603181.SH) disclosed the employee stock ownership plan (draft) for 2026, with the scope of participants including directors and key employees of the company (including subsidiaries), with a total initial number of not more than 48 people (excluding reserved parts). The source of the stock for the employee stock ownership plan is the company repurchasing Real Madrid Technology's A-shares common stock from the repurchase special account. The number of target stocks intended to be held in the employee stock ownership plan shall not exceed 6.5 million shares, representing approximately 1.10% of the total share capital of the company as of the date of the publication of this draft of the employee stock ownership plan.
Zhejiang Huangma Technology (603181.SH) disclosed its 2026 employee stock ownership plan (draft), with the scope of participation including the company (including subsidiaries) directors and core employees. The total number of participants at the initial establishment shall not exceed 48 persons (excluding reserved portions). The source of the stock for the employee stock ownership plan is the Zhejiang Huangma Technology A shares repurchased from the company's repurchase special account. The number of target shares planned to be held by the employee stock ownership plan shall not exceed 6.5 million shares, approximately 1.10% of the company's total equity on the date of the publication of the draft of the employee stock ownership plan.
The total amount of funds to be raised by the employee stock ownership plan is capped at 47.97 million yuan, with "shares" as the subscription unit, and each share priced at 1.00 yuan. The specific number of shares shall be determined based on the actual amount of capital contributions. The price for the employee stock ownership plan to purchase repurchased shares is 7.38 yuan per share.
Related Articles

MINIMAX-WP(00100): Hong Kong public offering receives 1837.17 times oversubscription

Golden Resources Development Limited (03636): The public sale in Hong Kong received 143.46 times oversubscription. The sale price per share is 30 Hong Kong dollars.

Sino Biopharmaceutical - B (06938): Hong Kong public offering receives 101.06 times oversubscription.
MINIMAX-WP(00100): Hong Kong public offering receives 1837.17 times oversubscription

Golden Resources Development Limited (03636): The public sale in Hong Kong received 143.46 times oversubscription. The sale price per share is 30 Hong Kong dollars.

Sino Biopharmaceutical - B (06938): Hong Kong public offering receives 101.06 times oversubscription.

RECOMMEND

Bank Of America Sees Three Drivers Supporting Chinese Consumer Stocks: Low Base, Deep Undervaluation, And Convertible‑Like Defensive Traits
07/01/2026

Cross‑Border E‑Commerce In 2025: Tariffs, Trade Wars, And Shifting Away From The United States
07/01/2026

Asian Stock Markets Record The Strongest Annual Start Ever As Shanghai Composite Hits Multi‑Year High And Sets Longest Winning Streak; Japan And Korea Rally
07/01/2026


